Please assess the completion status of the following clinical trial:

Trial Title: High Volume Lactated Ringer's Solution and Pancreatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients to be included in the study are those undergoing ERCP with the following:~* Clinical suspicion of sphincter of Oddi dysfunction~* History of post-ERCP pancreatitis (at least one episode)~* Pancreatic sphincterotomy~* Pre-cut (access) sphincterotomy~* Ampullectomy~Exclusion Criteria:~* Age \< 18 years old~* Intrauterine pregnancy or breastfeeding mother~* Congestive heart failure~* Advanced/symptomatic coronary artery disease~* Known ascites~* Renal failure~* Active or recent gastrointestinal hemorrhage~* Acute pancreatitis within 72 hours prior to ERCP

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- High Volume Group (Intervention Arm) (Type: EXPERIMENTAL): Patients will be randomized to receive intravenous Lactated Ringer's solution. In the high volume group (intervention arm), patients will receive fluids prior to, during, and after the completion of the procedure. Patients in the high volume group will receive fluids via infusion by the following weight based regimen:~* initial bolus of LR prior to ERCP of 7.5 cc/kg over 1 hour~* LR fluid infusion during the procedure at 5 cc/kg/hr~* Post-procedure bolus of 20 cc/kg over 90 minutes
- Low Volume Group (Control Arm) (Type: ACTIVE_COMPARATOR): Patients will be randomized to receive intravenous Lactated Ringer's solution. In the low volume group (control arm), patients will receive fluids at the start of the ERCP. The fluids will be administered via infusion at a rate of 1.5 cc/kg/hr. Fluids may be continued through the 90 minute post-procedure observation period.

Based on this trial design, predict the completion outcome and termination type (if applicable).